Doha: Sidra Medicine will host its 4th annual Pediatric Neuroscience Conference (PNC 2024) from 24-26 October, 2024. PNC 2024 is being held in partnership with Children’s National Hospital USA.
PNC 2024 will feature comprehensive scientific discussions on Pediatric Neurology, Neurosurgery, Neuro-critical care, Neurogenetics, Neuroimmunology, and Neuroradiology.
Dr. Husam Kayyali, Division Chief of Pediatric Neurology at Sidra Medicine and PNC 2024 Chair said: “At Sidra Medicine, we are not just treating neurological conditions; we are investing in the future of children’s health. The Pediatric Neuroscience Conference is a hub for sharing knowledge and driving innovation in pediatric neurosciences. This collaboration of brilliant minds will pave the way towards a brighter future for children in need of neurological and neurosurgical care. Our innovative work in personalized medicine, allows us to provide targeted therapies and a brighter future for every child.” PNC 2024 will also feature highlights on perso
nalized medicine in pediatric neurology such as the latest advances in the management of Spinal Muscular Atrophy (SMA). The hospital’s SMA gene therapy program has positioned Qatar as a regional pioneer in advanced genetic therapies for children with neurodegenerative diseases.
Dr. Ian Pople, Division Chief of Neurosurgery at Sidra Medicine said: “Our Pediatric Neuroscience Conference has always been about making a real difference in the lives of children with neurological conditions particularly those requiring neurosurgery. Partnering with Children’s National Hospital this year allows us to amplify that impact on a global scale. By hosting this pivotal event in Qatar, we are ensuring that the knowledge translates directly into personalized treatments for young patients across the region.” Over the years, the PNC conference has welcomed a diverse audience, including pediatric neurologists, neurosurgeons, pediatricians, primary care physicians, nurses, and medical students.
Source: Qatar News Agency
